Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- Check5 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA 403 error page is now displayed in place of the study details, masking the MOSAIC study information and navigation.SummaryDifference20%

- Check47 days agoChange Detected- Revision: v3.6.6 replaces v3.6.5 on the page, signaling a minor platform update. This change does not modify study details or user-facing study information.SummaryDifference0.0%

- Check54 days agoChange DetectedAn NIH grant/contract identifier (2016) was added to the study's list of other identifiers, capturing funding information associated with the MOSAIC trial.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.6.5 was added and v3.6.4 was removed, indicating a minor update to the page’s underlying version. It appears to be a background system/format change rather than content changes to the MOSAIC study page.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new iteration of the page content. It represents a minor update to the page rendering and does not change the information shown.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.